News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
BLATT LAWRENCE
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/17/2023 |
4
| BLATT LAWRENCE (CEO) has filed a Form 4 on Aligos Therapeutics, Inc.|
Txns:
| Granted 242,500 options to buy
@ $1.34, valued at
$325k
|
|
| 02/08/2023 |
SC 13G/A
| BLATT LAWRENCE reports a 6.5% stake in Aligos Therapeutics, Inc. |
| 07/11/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/10/2022 |
SC 13G/A
| BLATT LAWRENCE reports a 6.2% stake in Aligos Therapeutics, Inc. |
| 02/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/11/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 12/03/2020 |
4
| BLATT LAWRENCE (CEO) has filed a Form 4 on Aligos Therapeutics, Inc.|
Txns:
| Granted 450,000 options to buy
@ $16.18, valued at
$7.3M
|
|
| 10/20/2020 |
4
| BLATT LAWRENCE (CEO) has filed a Form 4 on Aligos Therapeutics, Inc.|
Txns:
| Converted 41,016 shares
@ $0
Converted 122,601 shares
@ $0
Converted 13,671 shares
@ $0
Converted 13,671 shares
@ $0
Converted 50,712 shares
@ $0
Converted 3,394 shares
@ $0
Converted 3,394 shares
@ $0
Converted 21,695 shares
@ $0
Converted 1,452 shares
@ $0
Converted 1,452 shares
@ $0
Converted 41,016 preferred shares
@ $0 |
|
| 10/15/2020 |
3
| BLATT LAWRENCE (CEO) has filed a Form 3 on Aligos Therapeutics, Inc. |
|
|